Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

NHS Framework for Midlands and East, Branded Medicines - Tranche A and Annual

NHS England

This public procurement record has 1 release in its history.

Award

22 Feb 2022 at 10:00

Award Notice
Summary of the contracting process

The NHS Framework for Midlands and East for Branded Medicines has been awarded by NHS England. This procurement process involves the supply of pharmaceutical products, with a contract value of £216,078,796. The framework period runs from 1st March 2022 to 1st March 2024, with potential extensions at the Authority's discretion. The tender process was conducted using an open procurement method, with the tender period concluding on 21st September 2021.

This tender presents lucrative opportunities for businesses in the pharmaceutical sector, particularly those offering branded medicines. Small and medium-sized enterprises (SMEs) as well as larger companies may find this framework suitable for participation. Companies involved in the supply chain of pharmaceutical products, especially those capable of meeting NHS quality standards and delivering to the designated UK regions, are encouraged to explore this contract to expand their market reach and establish long-term partnerships with NHS England.

How relevant is this notice?

Notice Information

Notice Title

NHS Framework for Midlands and East, Branded Medicines - Tranche A and Annual

Notice Description

NHS Framework for the Midlands and East, Branded Medicines - Tranche A and Annual Tranche Offer reference number: CM/PHR/20/5602 CM/PHR/20/5602/01 - NHS Framework for the Midlands and East, Branded Medicines - Tranche A. Period of framework: 1 March 2022 to 29 February 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months CM/PHR/20/5602/02 - NHS Framework for the Midlands and East Branded Medicines - Annual Tranche Products. Period of framework: 1 March 2022 to 28 February 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-b5fd17-844167bf-8922-4b36-9988-1ca1ea6c014f
Publication Source
Contracts Finder
Latest Notice
https://www.contractsfinder.service.gov.uk/Notice/8b4dda79-7a0f-4029-af57-8b797724dade
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
Award Notice
Procurement Type
Standard
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure (above threshold)
Tender Suitability
SME
Awardee Scale
Large, SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£216,078,796 £100M-£1B
Lots Value
Not specified
Awards Value
£216,078,796 £100M-£1B
Contracts Value
Not specified

Notice Dates

Publication Date
22 Feb 20224 years ago
Submission Deadline
21 Sep 2021Expired
Future Notice Date
Not specified
Award Date
7 Feb 20224 years ago
Contract Period
1 Mar 2022 - 1 Mar 2024 2-3 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Not Specified
Awards Status
Active
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
NHS England
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
RUNCORN
Postcode
WA7 2ES
Postcode Area
Warrington
Country
England
Major Region (ITL 1)
TLD North West (England)
Basic Region (ITL 2)
TLD7 Merseyside
Small Region (ITL 3)
TLD71 East Merseyside
Delivery Location
TLF East Midlands (England), TLG West Midlands (England)
Local Authority
Halton
Electoral Ward
Halton Lea
Westminster Constituency
Runcorn and Helsby

Supplier Information

Number of Suppliers
31
Supplier Names

Allergan

Accord-UK Ltd

Roche Products Ltd

Sandoz Ltd

Amgen Ltd

Napp Pharmaceuticals Ltd

Novo Nordisk

Pfizer Ltd

Vifor Pharma UK Ltd

Ipsen

Janssen-Cilag Ltd

Teva UK Limited

Merck Serono Limited

Chugai Pharma UK Ltd

Pharmacosmos UK Ltd

Merz

Eli Lilly & Company Ltd

Merck Sharpe & Dohme (UK) Limited

Zentiva Pharma UK Ltd

THORNTON & ROSS LIMITED

ASTRAZENECA UK LIMITED

BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED

GlaxoSmithKline UK Limited

Swedish Orphan Biovitrum Ltd

Celltrion Healthcare

Almirall

Takeda UK Limited

AVENTIS PHARMA LIMITED t-a Sanofi

Gedeon Richter UK Ltd

Organon Pharmaceuticals UK Ltd

UCB Pharma Ltd

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...